Stay updated with the latest breakthroughs and developments from our research team in our efforts against antimicrobial resistance and infectious diseases. You can find CAMO-Net specific news here.
Professor Alison Holmes appointed inaugural Director of the Fleming Initiative
October 2024
Professor Alison Holmes, David Price Evans Chair of Global Health and Infectious Diseases at the University of Liverpool, has been appointed as the inaugural Director of the Fleming Initiative.
Established by Imperial College London and Imperial College Healthcare NHS Trust, the Fleming Initiative brings together research scientists, policymakers, clinicians, behavioural experts, public and commercial partners to provide the networks, expertise and skills to find equitable solutions to AMR at the global scale.
Dr Derek Cocker publishes paper in BMJ Future Shocks Series
Members of the David Price Evans Group at the University of Liverpool have published a pivotal paper that addresses the urgent need for comprehensive, system-wide approaches to reduce healthcare-associated infections (HAIs) and antimicrobial resistance (AMR). The paper, "Protecting healthcare and patient pathways from infection and antimicrobial resistance," is part of the newly launched BMJ collection on Research Priorities for Future Shocks, developed in partnership with the Health Foundation.
Read more...
Dr Sanjiv Sharma joins David Price Evans Group
August 2024
Biomedical engineer Dr Sanjiv Sharma has joined The David Price Evans (DPE) Global Health and Infectious Diseases Group at the University of Liverpool as a Senior Lecturer. Dr Sharma brings a wealth of experience and expertise from his time at Swansea University, where he oversaw implant engineering research at their Department of Engineering. His work focuses on therapeutic drug delivery and diagnostic applications of polymeric microneedles.
Read more...
DPE Group awarded £1.3m Fleming Fund
April 2024
The DPE Group has been awarded £1.3m funding to support the UK Government’s Fleming Fund Fellowship Programme.
The funding will support mentorship and a programme of tailored professional development for practitioners and influencers who are engaged in antimicrobial resistance (AMR) surveillance in Fleming Fund partner countries.
AI blueprint to help tackle antimicrobial resistance on a global scale
December 2023
Researchers from the DPE Group have outlined a framework for artificial intelligence (AI) to improve antimicrobial use and infection care, helping to address the global challenge of antimicrobial resistance (AMR).
Their blueprint is detailed in a research paper published today (18 December 2023) in The Lancet Digital Health.
Liverpool welcomes antimicrobial network partners
June 2023
The University of Liverpool recently hosted the first official gathering of the global partners from the Centres for Antimicrobial Optimisation Network (CAMO-Net) for a welcome reception and the inaugural CAMO-Net Management Board Meeting.
CAMO-Net is formed by five ‘national hubs’, which are made up of research teams from the University of Liverpool and Imperial College London, the University of Cape Town in South Africa, the Infectious Diseases Institute in Uganda, and the Faculty of Medicine at the University of São Paulo in Brazil.
New global research consortium to optimise antimicrobial use in humans
April 2023
Research teams from institutions in Africa, Asia, Europe and South America are coming together to form the Centres for Antimicrobial Optimisation Network (CAMO-Net). With up to £11m in funding from Wellcome, this ground-breaking consortium will support translational research to address a major driver of antimicrobial resistance, using a bespoke funding model to help enhance global health research equity.
The David Price Evans Group welcomes Dr Derek Cocker
April 2023
Dr Derek Cocker joined the group as an NIHR Clinical Lecturer in Infectious Diseases and Global Health, a role which will see him combining academic research with the final phase of his clinical training.
Derek has keen research interests in evaluating the One Health drivers of antimicrobial resistance and will be conducting a number of projects during his time with the Group. Derek previously completed his PhD at the Liverpool School of Tropical Medicine, with a thesis entitled: 'An investigation into the role of human, animal and environmental factors on transmission of ESBL E. coli and ESBL K. pneumoniae in southern Malawian communities' and has spent time working in in Malawi, Uganda and Tanzania before returning to Liverpool. He will be developing projects seeking to evaluate how preventative action such as health interventions targeted at high-risk groups can improve infection and AMR outcomes in high income and low-resource settings and assess novel opportunities in responsive environmental surveillance methodologies.
Professor Alison Holmes said of his appointment: “I am delighted that the University of Liverpool, and the group in particular, has been able to attract such a talented doctor and researcher to join us. Supporting the next generation of clinical academics and launching them on ambitious career trajectories is the best part of my role and it is a real delight to be working with Derek.”
Dr Esmita Charani awarded prestigious Wellcome Trust Career Development Fellowship
March 2023
Dr Esmita Charani, a Reader in the David Price Evans Group in the Department of Pharmacology and Therapeutics, has been awarded a prestigious Wellcome Trust Career Development Fellowship to further her research in applying social sciences to the challenges of antimicrobial resistance (AMR).
This four-year fellowship will see Dr Charani carry out a body of research based at the University of Cape Town (UCT), South Africa, investigating the intersectionality of power dynamics, hierarchies, and health-seeking and health-providing behaviours in hospital settings across different cultural boundaries in South Africa and India.
People of colour: there’s a bias in how pictures are used in global health publications
January 2023
By Dr Esmita Charani, Reader in AMR and global health at the University of Liverpool and Marc Mendelson, Professor of Infectious Diseases at the University of Cape Town.
Photography is a powerful tool in storytelling and scientific communication. But it can also cause harm when used unethically.
We started to realise how photographs can send the wrong message when we were approached, as a group of infectious disease specialists, to develop a presentation on resistance to antibiotics. Our audience was a clinical group in east Africa.
Professor Alison Holmes OBE FMedSci appointed as David Price Evans Chair in Global Health and Infectious Diseases
September 2022
Professor Alison Holmes OBE FMedSci, has been appointed as the David Price Evans Chair in Global Health and Infectious Diseases at the University of Liverpool.
Alison has longstanding collaborations with Liverpool colleagues and previous ties with the University, serving on external advisory panels. She will be developing the David Evans Price Global Health and Infectious Diseases research group, with a focus on antimicrobial optimisation and the prevention and management of infectious diseases. Alison also has a variety of International, European and National roles. She is the current President of the International Society of Infectious Diseases (ISID), Director of the NIHR Health Protection Research Unit and Centre for Antimicrobial Optimisation at Imperial College London, and an NIHR Senior Investigator.
Back to: Institute of Systems, Molecular and Integrative Biology